Keywords: هموفیلی A; aFVII; activated FVII; AHA; acquired hemophilia A; anti-hFVIII; anti-human FVIII; aPCC; activated prothrombin complex concentrate; aPTT; activated partial thromboplastin time; AT; antithrombin; AUC; area under the curve; BPA; bypassing agent; BU; Bethesda
مقالات ISI هموفیلی A (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: هموفیلی A; Hemophilia A; Factor VIII inhibitor; Inhibitor by passing activity; Activated prothrombin concentrate; Recombinant activated factor VII; Factor VIII; Novel agents; TFPI antagonists; ATIII antagonist; Concizumab; Emicizumab; Alpha 1 antitrypsin;
Keywords: هموفیلی A; Factor VIII; Hemophilia A; Blood coagulation; Recombinant proteins; Glycoprotein; Glycosylation;
Keywords: هموفیلی A; phospholipids; liposomes; apoptosis; immune response; proteins; biotechnology; HA; Hemophilia A; FVIII; factor VIII; GAA; acid alpha glucosidase; rhGAA; recombinant human GAA; PS; phosphatidylserine; TIM-4; T-cell immunoglobulin and mucin 4; MOG; myelin o
Keywords: هموفیلی A; Hemofilia B; Hemofilia A; Dolor; Analgésicos opioides; Dolor agudo; Hemophilia B; Hemophilia A; Pain; Analgesics, opioid; Acute pain;
Keywords: هموفیلی A; Hemophilia B; Hemophilia A; Pain; Analgesics opioid; Acute pain; Hemofilia B; Hemofilia A; Dolor; Analgésicos opioides; Dolor agudo;
Keywords: هموفیلی A; budget impact; economic impact; hemophilia A; rFVIIIFc;
Keywords: هموفیلی A; Hemophilia A; Hemophilia B; Bleeding; Mutations; Thrombophilia;
Keywords: هموفیلی A; Hemophilia A; Factor VIII; Inhibitors; Innate immunity; Clearance; Immune tolerance; Antigen presenting cells;
Keywords: هموفیلی A; aPCC; activated prothrombin complex concentrate; aPL; antiphospholipid; FIX; factor IX; FMD; flow-mediated dilatation; FV; factor V; FVIII; factor VIII; HA; hemophilia A; HB; hemophilia B; HIV; human immunodeficiency virus; IMT; intima-media thickness; MT
Keywords: هموفیلی A; Gene therapy; Hemophilia A; Hemophilia B; Adeno-associated virus; Clinical trial;
Keywords: هموفیلی A; Hemophilia A; Simultaneous total knee arthroplasty; Cost-benefit analysis; Bilateral knee replacement
Keywords: هموفیلی A; Hemophilic pseudotumor; Hemophilia A
Keywords: هموفیلی A; Hemophilia A; Hemophilia B; Inhibitors; NovoSeven®; rVIIa-FP; PROLONG-7FPFEIBA®, Factor Eight Bypassing Activity; FIX, factor IX; FVII, factor VII; FVII:Ag, factor VII antigen; FVIIa, activated factor VII; FVIII, factor VIII; INR, international normalized
Application of the ISTH bleeding score in hemophilia
Keywords: هموفیلی A; Hemophilia A; Hemophilia B; ISTH; Bleeding assessment tool; Inherited bleeding disorders;
Subcutaneous administration of Lyso-phosphatidylserine nanoparticles induces immunological tolerance towards Factor VIII in a Hemophilia A mouse model
Keywords: هموفیلی A; FVIII; Factor VIII; PS; phosphatidylserine; HA; Hemophilia A; Tregs; regulatory T cells; Lyso-PS; Lyso-phosphatidylserine; DMPC; dimyrisotylphosphatidylcholine; OVA; ovalbumin; GFP; green fluorescent protein; SC; subcutaneous; IV; intravenous; APC; antige
Development and Validation of an Algorithm for Identifying Patients with Hemophilia A in an Administrative Claims Database
Keywords: هموفیلی A; algorithm; hemophilia A; predictive model; validation;
Risques en dermatologie interventionnelle chez les patients hémophiles ou atteints de la maladie de Willebrand
Keywords: هموفیلی A; Hémophilie A; Hémophilie B; Maladie de Willebrand; Chirurgie dermatologique; Risque hémorragique; Hemophilia A; Hemophilia B; Von Willebrand disease; Dermatologic surgery; Bleeding complications;
Evaluation of the activity levels of rat FVIII and human FVIII delivered by adeno-associated viral vectors both in vitro and in vivo
Keywords: هموفیلی A; Hemophilia A; Rat factor VIII; Human factor VIII; Dual-chain strategy; Single-chain strategy;
Biochemical characterization and immunogenicity of Neureight, a recombinant full-length factor VIII produced by fed-batch process in disposable bioreactors
Keywords: هموفیلی A; Hemophilia A; Factor VIII; Immunogenicity; Disposable fed-batch production technology; CHO cell line;
Surgical management of an enormous subgaleal hematoma accompanying occipital bone's destruction in a 30Â years old man with a history of hemophilia A
Keywords: هموفیلی A; Neurosurgery; Factor VII; Enormous subgaleal hematoma with epidural extension, occipital bone's destruction; Hemophilia A;
Oxidation of factor VIII increases its immunogenicity in mice with severe hemophilia A
Keywords: هموفیلی A; Hemophilia A; Oxidative stress; FVIII immunogenicity; FVIII inhibitors;
The effect of unmeasurable endogenous plasma factor activity levels on factor VIII dosing in patients with severe hemophilia A
Keywords: هموفیلی A; Factor VIII; Hemophilia A; Individualized medicine; Patient-specific modeling; Pharmacokinetics;
Review of immune tolerance induction in hemophilia A
Keywords: هموفیلی A; Hemophilia A; Inhibitors; Anti-FVIII antibodies; Immune tolerance induction (ITI); Working mechanism;
Successful medical management of a neonate with spontaneous splenic rupture and severe hemophilia A
Keywords: هموفیلی A; Factor VIII deficiency; Hemophilia A; Neonate; Splenic rupture;
T cell response to FVIII
Keywords: هموفیلی A; FVIII inhibitor; Hemophilia A; T cells; Immune tolerance induction;
BAY 81-8973, a full-length recombinant factor VIII: Human heat shock protein 70 improves the manufacturing process without affecting clinical safety
Keywords: هموفیلی A; BAY 81-8973; Cell line; Hemophilia A; HSP70; Manufacturing;
War and peace: Factor VIII and the adaptive immune response
Keywords: هموفیلی A; Hemophilia A; Factor VIII; Inhibitors; Adaptive immune response; B cells; Plasma cells;
Hunting down factor VIII in the immunopeptidome
Keywords: هموفیلی A; FVIII; Hemophilia A; Mass spectrometry; Inhibitors; Peptide presentation;
F8 gene mutation profile in Indian hemophilia A patients: Identification of 23 novel mutations and factor VIII inhibitor risk association
Keywords: هموفیلی A; FVIII inhibitors; F8 mutations; Hemophilia A; Risk factors
Effect of Biophysical Properties of Phosphatidylserine Particle on Immune Tolerance Induction Toward Factor VIII in a Hemophilia A Mouse Model
Keywords: هموفیلی A; protein delivery; lipids; phosphatidylserine; immunology; immune tolerance; BMDCs; bone marrow derived dendritic cells; FVIII; factor VIII; HA; hemophilia A; Nabs; anti-FVIII neutralizing antibodies; PS; phosphatidylserine;
Principles of genetic variations and molecular diseases: applications in hemophilia A
Keywords: هموفیلی A; Hemophilia A; Gene targeting; F8 gene mutations; Mutation analysis; CNV; Inversion; Molecular Biology methods;
Tolerogenic nanoparticles to induce immunologic tolerance: Prevention and reversal of FVIII inhibitor formation
Keywords: هموفیلی A; FVIII protein; Human; Hemophilia A; Immune tolerance; PLGA; Rapamycin; Nanoparticles;
Strategies to target long-lived plasma cells for treating hemophilia A inhibitors
Keywords: هموفیلی A; Factor VIII; Hemophilia A; Inhibitors; Plasma cells; Immune tolerance; Immunomodulation; AMD3100; G-CSF;
B-cell memory against factor VIII
Keywords: هموفیلی A; Hemophilia A; FVIII-specific antibodies; Neutralizing and non-neutralizing antibodies; Memory B cells; Immune regulation;
Recombinant factor VIII Fc (rFVIIIFc) fusion protein reduces immunogenicity and induces tolerance in hemophilia A mice
Keywords: هموفیلی A; FVIII; factor VIII; rFVIIIFc; recombinant human factor VIII Fc; BDD; B-domain deleted; FL-rFVIII; full length recombinant factor VIII; Treg; regulatory T-cells; TNF-α; tumor necrosis factor-α; IFN-γ; Interferon-γ; Hemophilia A; Immune tolerance; Regul
Targeting of the human F8 at the multicopy rDNA locus in Hemophilia a patient-derived iPSCs using TALENickases
Keywords: هموفیلی A; Hemophilia A; iPSCs; Ribosomal DNA; Multicopy; TALENickases;
Joint SOGC-CCMG Opinion for Reproductive Genetic Carrier Screening: An Update for All Canadian Providers of Maternity and Reproductive Healthcare in the Era of Direct-to-Consumer Testing
Keywords: هموفیلی A; Carrier screening; prenatal screening; autosomal recessive disorder; autosomal dominant disorder; X-linked disorder; thalassemia; hemoglobinopathy; cystic fibrosis; Duchenne/Becker muscular dystrophy; Fragile X; spinal muscular atrophy; Tay-Sachs disease;
Opinion commune de la SOGC et du CCGM sur le dépistage génétique en contexte de procréation : Mise à jour à l'intention de l'ensemble des prestataires canadiens de soins de santé maternelle et de services en procréation, à l'ère des tests offerts dire
Keywords: هموفیلی A; Carrier screening; prenatal screening; autosomal recessive disorder; autosomal dominant disorder; X-linked disorder; thalassemia; hemoglobinopathy; cystic fibrosis; Duchenne/Becker muscular dystrophy; Fragile X; spinal muscular atrophy; Tay-Sachs disease;
Découverte fortuite d'une hémophilie A mineure lors d'une circoncision
Keywords: هموفیلی A; Hémophilie A; Mineure; Hémorragie; Circoncision; Sporadique; Desmopressine; Hemophilia A; Minor; Hemorrhage; Circumcision; Sporadic; FXIII hemophilia; Desmopressin;
Manufacturing process used to produce long-acting recombinant factor VIII Fc fusion protein
Keywords: هموفیلی A; rFVIIIFc; Human cell line; HEK 293H; Hemophilia A; Manufacturing; Recombinant; aPTT; activated partial thromboplastin time; α-Gal; galactose-α-1,3-galactose; BDD; B domain-deleted; FcRn; neonatal Fc receptor; FVIII; factor VIII; HC; heavy chain; HCP; ho
Overrepresentation of missense mutations in mild hemophilia A patients from Belgium: founder effect or independent occurrence?
Keywords: هموفیلی A; hemophilia A; Factor VIII; Genetics of Thrombosis and Haemostasis; mutation analysis; microsatellites;
Cost-Utility Analysis of Home-Based Care for Treatment of Thai Hemophilia A and B
Keywords: هموفیلی A; cost-utility; factor VIII concentrate; factor IX concentrate; hemophilia A; hemophilia B;
Influence of factor 5 rs6025 and factor 2 rs1799963 mutation on inhibitor development in patients with hemophilia A - an Israeli-German multicenter database study
Keywords: هموفیلی A; BU; Bethesda units; ED; exposure days; F2; Factor 2 rs1799963; F5; Factor 5 rs6025; FVIII; Factor VIII; F8; Factor 8 genotypes; HA; hemophilia A; HRI; high-titer inhibitor; HR/CI; hazard ratio/confidence interval; ICH; intracranial hemorrhage; IFS; inhibi
Murine leukemia virus-derived retroviral vector has differential integration patterns in human cell lines used to produce recombinant factor VIII
Keywords: هموفیلی A; Factor VIII; Virus integration; Hemophilia A
Drug-drug interaction of the anti-TFPI aptamer BAX499 and factor VIII: Studies of spatial dynamics of fibrin clot formation in hemophilia A
Keywords: هموفیلی A; BAX499; coagulation; drug-drug interaction; hemophilia A; spatial propagation;
Modeling of hemophilia A using patient-specific induced pluripotent stem cells derived from urine cells
Keywords: هموفیلی A; Hemophilia A; Clotting factor VIII; Induced pluripotent stem cells; Directed differentiation in vitro
Separation of intron 22 inversion type 1 and 2 of hemophilia A by modified inverse-shifting polymerase chain reaction and capillary gel electrophoresis
Keywords: هموفیلی A; Hemophilia A; Intron 22 inversion Type 1 and 2; Capillary electrophoresis; Inverse-shifting polymerase chain reaction
Overexpression of factor VII ameliorates bleeding diathesis of factor VIII-deficient mice with inhibitors
Keywords: هموفیلی A; FVII; Factor VII; FVIII; Factor VIII; AAV; adeno-associated virus; F8KO; Factor VIII knock out; HCR; hepatic control region; HAAT; human alpha-1 antitrypsin; CMV; cytomegalovirus; SV40; simian virus 40; PCR; polymerase chain reaction; PT; prothrombin time
An induced pluripotent stem cell-mediated and integration-free factor VIII expression system
Keywords: هموفیلی A; Human artificial chromosome; Induced pluripotent stem cells; Sendai virus vector; Integration-free; Hemophilia A; Factor VIII;